Table 3.
Plasma saturated and monounsaturated fatty acids profile and estimated enzymatic activities indices in BD patients and controls.
| - | Controls (n=99) | BD Patients (n=101) | ||
|---|---|---|---|---|
| - | % | µg/ml | % | µg/ml |
| MA (C14:0) | 0.63 (0.50-0.84) | 26.28 (17.87-40.28) | 0.75 (0.55-0.98)* | 27.96 (19.46-42.49)* |
| PAM (C16:0) | 21.87 (20.25-23.26) | 856.17 (622.15-1082.05) | 22.31 (20.87-24.88)* | 881.54 (664.0-106.69)* |
| STA (C18:0) | 6.09 (5.26-6.70) | 237.45 (182.05-304.20) | 6.04 (5.31-7.59) | 233.11 (174.75-311.84) |
| Total SFA | 28.49 (26.67-30.98) | 1070.70 (891.52-1376.28) | 29.65 (27.24-32.43)* | 1156.77 (818.69-1408.79)* |
| POA (C16:1n-7) | 2.94 (2.01-4.26) | 107.27 (72.56-168.15) | 3.88 (2.72-5. 51)** | 130.13 (89.08-188.76)* |
| OLA (C18:1n-9) | 21.5 (19.79-23.66) | 639.81 (465.18-892.30) | 20.7 (18.78-23.28) | 584.72 (429.67-827.62) |
| Total MUFA | 24.73 (22.88-27.09) | 707.27 (543.81-976.93) | 25.25 (22.52-28.4) | 741.23 (536.35-1064.83) |
| Elongase | 0.28 (0.24-0.31) | 0.28 (0.25-0.31) | 0.27 (0.23-0.32) | 0.27 (0.23-0.32) |
| SCD-16 | 0.13 (0.09-0.19) | 0.12 (0.09-0.178) | 0.17 (0.12-0.24)** | 0.15 (0.11-0.21)* |
| SCD-18 | 3.55 (2.91-4.49) | 2.73 (2.27-3.46) | 3.30 (2.53-4.37) | 2.53 (1.98-3.40) |
BD: Behcet Disease; MA: Mystiric. PAM: Palmitic acid; STA: Stearic acid; POA: Palmitoleic acid; OLA: Oleic acid; SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; SCD: Stearoyl CoA desaturase; %: percentage; µg:microgram ; ml: milliliter;µmol: micromole; *: p ≤ 0,05; **: p ≤ 0,001.